NICE technology appraisal guidance No.61 on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer

Following consultation, the majority of comments received have led to the agreement that the existing guidance on capecitabine and tegafur uracil for metastatic colorectal cancer becomes static guidance.

The list of static technology appraisal guidance will be updated accordingly.